Search results
Ozempic Slows Kidney Disease, Novo Nordisk Study Finds
The Wall Street Journal· 6 hours agoNovo Nordisk’s Ozempic drug slows the progression of chronic kidney disease and cuts the risk of...
8 Things Knee Doctors Say You Should Never, Ever Do
BuzzFeed via Yahoo News· 16 hours ago“Once a diagnosis is made, then the appropriate treatment plan can be initiated.” They don’t skip warmups. Martin Novak / Getty Images Before... said....
HSS Launches Clinical Trial to Address Post-Traumatic Osteoarthritis after ACL Revision Surgery
CBS 47 Fresno· 4 days agoUp to 18% of patients undergoing ACL reconstruction experience graft failure and require revision surgery, which is known to increase the risk of developing post-traumatic osteoarthritis ...
... Strategy for its Next Generation, Disease-Modifying, Non-Opioid Analgesic Gene Therapies for the...
The Kansas City Star· 3 days agoDevelopment program for the treatment of osteoarthritis (OA) chronic knee pain is fully funded through the first-in-human clinical study by a UG3/UH3 grant awarded by NIH/NINDS HEAL program
Fit for a dog? The latest science on CBD for pets
Popular Science via Yahoo News· 8 hours agoThis article was originally featured on Knowable Magazine. 13-year-old Norwich terrier, previously limping and stiff, able to enjoy walks again. A toy...
New fat-based treatment could replace anesthesia for joint pain
WFLA via Yahoo News· 2 days agoKAUNAS, LITHUANIA (BLOOM) – Joint pain isn’t just for older adults anymore. It’s becoming more...
What To Know and Do About Collarbone Pain
Health via Yahoo News· 1 day agoCollarbone or clavicle pain has many causes, from injuries to underlying health conditions. Home remedies, medications, and therapies can offer relief.
More men with enlarged prostates turning to less invasive treatment
CBS News· 4 days agoRowe Winecoff of Edina is about to undergo treatment for benign prostatic hyperplasia, or BPH — a...
Further CYP-001 GvHD Clinical Data Published in Nature Medicine
CBS 47 Fresno· 2 days agoCYP-001 is Cynata's Cymerus™ off-the-shelf iPSC[1]-derived MSC[2] product for intravenous infusion, which is being investigated as a potential immune modulating treatment.
Novo’s Ozempic Slashes Risk of Death in Kidney Disease Study
Bloomberg via Yahoo Finance· 9 hours ago(Bloomberg) -- Novo Nordisk A/S’s blockbuster diabetes drug Ozempic cut patients’ risk of dying in a...